About HMR London
HMR London is a Healthcare company based in London (United Kingdom) founded in 1993, and was acquired by Nucleus Network in August 2025. CRO which has worked in 670 trials and specializes in early stage clinical trials. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Early Stage. Its legal entity is HMR LIMITED. Its competitors include Open Orphan, AWAKN and Clerkenwell Health; 1 of its 3 listed competitors has raised funding.
Company details
Hammersmith Medicines Research (HMR) London is an early stage CRO specializing in First-In-Human studies and over 20 years of clinical trial experience. Their FIH services include Japanese bridging studies, ADME and light label studies, BABE studies, thorough QT studies and several others. They have capabilities to carry out studies involving measurement of respiratory function, sleep monitoring, endoscopy, radiolabeling, biomarkers and audiometry. They claim to be the first UK CRO to get a manufacturing authorization for IMPs and MHRAs phase I accreditation.
- Headquarters London, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website hmrlondon.com
- Social LinkedIn X Facebook
- Acquired by Nucleus Network (Aug 2025)
- Legal Name Hmr Limited
- Date of Incorporation 09 Dec, 1999
- Jurisdiction LONDON
- Latest Funding Round$30.23K (USD), Grant
Apr 2020
- InvestorsEuropean Union
& 2 more
- Acquired byNucleus Network
(Aug 2025)
Funding Insights of HMR London
- Total Rounds 3
- Last Round Grant — $30,230
- Investors Count 2
All 3 funding rounds of HMR London with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | $30,230 | Grant | – | – | |
| Oct 2015 | $55,006 | Grant | – | – | |
| May 2015 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in HMR London
HMR London has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Nucleus Network and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Clinical trial services are provided for medical research and development. | 2003 | nucleusnetwork.com | Saint Paul, United States |
Investor details for HMR London
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of HMR London
16 people are tracked at HMR London (10 in leadership, 1 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Denisa Wilkes | Medical Director | Leadership |
Nick Jackson | Associate Director of Statistics & Programming | Leadership |
Kirsten Heukelbach | Head of Pharmacy | Leadership |
Temitope Adeloye | Senior Research Physician, Principal Investigator & Head of Pharmacovigilance | Leadership |
Stephen Smith | Director of Corporate Services | Leadership |
Lizelle Krige | Chief Biomedical Scientist | Leadership |
Juan Naveda | Director of Laboratory Services | Leadership |
Afia Khatun Miah | Head of Quality Assurance & Monitoring | Leadership |
Malcolm Boyce | Executive Chairman & Senior Medical Director | Leadership |
Stephen Sah | Head Of Statistics | Leadership |
Steve Warrington | Chief Medical Adviser | Board & advisors |
John Salter | Consultant Statistician | Team |
Luke Benjamin | Principal Pharmacist & Production Manager | Team |
Paul Bates | Computer System Validation & IT Compliance Manager | Team |
Megan A. | Recruitment & Screening Associate | Team |
Sarah Boulton | Enquiries Manager | Team |
Complete people profiles for HMR London
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of HMR London
4 dated milestones of HMR London across 32 years, from founding to its latest funding, stage changes and deals.
- Founded HMR London is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $30K.
- Exit Acquired by Nucleus Network.
Competitors of HMR London
HMR London has 3 listed competitors in our database, 1 of them funded. They include Open Orphan, AWAKN and Clerkenwell Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| openorphan.com | 2017 | London, United Kingdom | 218 | Provider of testing vaccines & antivirals and CRO pharmaceutical services | ||
| awaknlifesciences.com | 2020 | Portishead, United Kingdom | 49 | CRO focused on early stage clinical trial research | ||
| clerkenwellhealth.com | 2020 | London, United Kingdom | $2.33M | CRO focused on conducting early stage clinical development of psychedelic medicines |
Detailed competitors of HMR London
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of HMR London
The website of HMR London (hmrlondon.com) receives about 7.5K visits a month.
- Monthly visits7.5K
▲ 46.4% vs previous month
Websites whose visitors overlap most with HMR London. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
londontrials.com | londontrials.com | 100% | #601,753 | – | |
42group.co.uk | 42group.co.uk | 84% | #5,188,533 | – | |
drugtrial.co.uk | drugtrial.co.uk | 83% | #6,951,751 | – | |
soft.org.uk | soft.org.uk | 82% | #3,022,727 | – | |
| carrotrecruitment.co.uk | 76% | 680.7K | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for HMR London
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hmr London
Complete news archive for HMR London
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HMR London
HMR London was founded in 1993 and raised its 1st funding round 22 years after it was founded.
HMR London is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Hammersmith Medicines Research (HMR) London is an early stage CRO specializing in First-In-Human studies and over 20 years of clinical trial experience. Their FIH services include Japanese bridging studies, ADME and light label studies, BABE studies, thorough QT studies and several others. They have capabilities to carry out studies involving measurement of respiratory function, sleep monitoring, endoscopy, radiolabeling, biomarkers and audiometry. They claim to be the first UK CRO to get a manufacturing authorization for IMPs and MHRAs phase I accreditation.
HMR London's top competitors include AWAKN, Open Orphan and Clerkenwell Health.
HMR London has 3 investors. Key investors include European Union, Nucleus Network, and EIC Fund.
HMR London operates through Hmr Limited.
Yes. HMR London was acquired by Nucleus Network in August 2025.